Related Experiment Video
Updated: May 24, 2025
07:49
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
90
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis
Edward Christopher Dee1, Mathieu Laversanne2, Nirmala Bhoo-Pathy3
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
The Lancet. Oncology
|March 2, 2025
Summary
Cancer incidence and mortality in Southeast Asia are high, with breast cancer in women and lung cancer in men being most common. Infection-related cancers like liver and cervical cancer are also prevalent, necessitating strengthened regional collaborations for cancer control.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Southeast Asia faces a significant burden of cancer morbidity and mortality.
- Understanding cancer statistics is crucial for informing research, health services, and policy in the region.
Purpose of the Study:
- To present and interpret cancer incidence and mortality data for 11 Southeast Asian countries.
- To provide insights for future cancer research priorities and public health strategies.
Main Methods:
- Utilized GLOBOCAN 2022 database for cancer incidence and mortality data.
- Calculated age-standardised incidence rates (ASIRs) and mortality rates (ASMRs).
- Projected cancer statistics to 2050 based on 2022 estimates and population forecasts.
Main Results:
- In 2022, over 1.1 million incident cancer cases and over 700,000 deaths were estimated in Southeast Asia.
- Singapore reported the highest overall cancer ASIRs, while Laos and Brunei had the highest ASMRs for men and women, respectively.
- Breast cancer was the leading cancer in women, lung cancer in men, and liver cancer was significant in several countries. Projections indicate a substantial increase in cancer cases by 2050.
Conclusions:
- Breast and lung cancers are primary drivers of cancer burden in Southeast Asia.
- Infection-related cancers (liver, cervix) remain significant in specific countries.
- Enhanced regional collaboration is essential for improving cancer prevention, diagnosis, care, and research.
Related Concept Videos
01:21Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
01:20Actuarial Approach
53
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
53
01:25Statistical Methods for Analyzing Epidemiological Data
280
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
280
01:20Comparing the Survival Analysis of Two or More Groups
117
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
117
01:24Kaplan-Meier Approach
75
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
75
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K